Study to Assess Adverse Events (AEs) When Oral Atogepant Tablet is Given to Adult Chinese Participants Who Completed Study 3101-303-002 to Prevent Chronic Migraine
Clinical trial NCT04829747 · COMPLETED
Trial details
- NCT number
- NCT04829747
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-02
- Primary completion
- 2022-01-20
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.